BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 25538945)

  • 1. ErbB4 as a potential molecular target in the treatment of esophageal squamous cell cancers.
    Zhao K; Chen BJ; Chen ZG
    ScientificWorldJournal; 2014; 2014():124105. PubMed ID: 25538945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reciprocal effects between microRNA-140-5p and ADAM10 suppress migration and invasion of human tongue cancer cells.
    Kai Y; Peng W; Ling W; Jiebing H; Zhuan B
    Biochem Biophys Res Commun; 2014 Jun; 448(3):308-14. PubMed ID: 24530397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA Erbb4-IR promotes esophageal squamous cell carcinoma (ESCC) by downregulating miR-145.
    Zhang Y; Zhang L; Wang R; Wang B; Hua P; Li J
    J Cell Biochem; 2019 Oct; 120(10):17566-17572. PubMed ID: 31119810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stable knockdown of Aurora-A by vector-based RNA interference in human esophageal squamous cell carcinoma cell line inhibits tumor cell proliferation, invasion and enhances apoptosis.
    Wang X; Dong L; Xie J; Tong T; Zhan Q
    Cancer Biol Ther; 2009 Oct; 8(19):1852-9. PubMed ID: 19770595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-139-5p inhibits cell proliferation and invasion by targeting insulin-like growth factor 1 receptor in human non-small cell lung cancer.
    Xu W; Hang M; Yuan CY; Wu FL; Chen SB; Xue K
    Int J Clin Exp Pathol; 2015; 8(4):3864-70. PubMed ID: 26097570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-219-5p plays a tumor suppressive role in colon cancer by targeting oncogene Sall4.
    Cheng J; Deng R; Zhang P; Wu C; Wu K; Shi L; Liu X; Bai J; Deng M; Shuai X; Gao J; Wang G; Tao K
    Oncol Rep; 2015 Oct; 34(4):1923-32. PubMed ID: 26238082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etoposide-induced MicroRNA-205-5p Suppresses Proliferation and Migration by Targeting ERBB4 in MCF-7 Cells.
    Son SW; Heo SH; Oh SS; Lee CH; Park JK
    Anticancer Res; 2022 Sep; 42(9):4265-4272. PubMed ID: 36039421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting oncogenic PLCE1 by miR-145 impairs tumor proliferation and metastasis of esophageal squamous cell carcinoma.
    Cui XB; Li S; Li TT; Peng H; Jin TT; Zhang SM; Liu CX; Yang L; Shen YY; Li SG; Li N; Li Y; Hu JM; Jiang JF; Suo J; Qi Y; Liang WH; Wang LH; Dang HW; Li L; Cao WW; Wei Y; Laibo-Yin ; Wu CY; Yuan XL; Zhou H; Zheng Y; Chen YZ; Li F
    Oncotarget; 2016 Jan; 7(2):1777-95. PubMed ID: 26657507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-144 affects radiotherapy sensitivity by promoting proliferation, migration and invasion of breast cancer cells.
    Yu L; Yang Y; Hou J; Zhai C; Song Y; Zhang Z; Qiu L; Jia X
    Oncol Rep; 2015 Oct; 34(4):1845-52. PubMed ID: 26252024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-promoting function of single nucleotide polymorphism rs1836724 (C3388T) alters multiple potential legitimate microRNA binding sites at the 3'-untranslated region of ErbB4 in breast cancer.
    Bagheri F; Mesrian Tanha H; Mojtabavi Naeini M; Ghaedi K; Azadeh M
    Mol Med Rep; 2016 May; 13(5):4494-8. PubMed ID: 27035115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-139-5p inhibits the biological function of breast cancer cells by targeting Notch1 and mediates chemosensitivity to docetaxel.
    Zhang HD; Sun DW; Mao L; Zhang J; Jiang LH; Li J; Wu Y; Ji H; Chen W; Wang J; Ma R; Cao HX; Wu JZ; Tang JH
    Biochem Biophys Res Commun; 2015 Oct; 465(4):702-13. PubMed ID: 26299922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive gene and microRNA expression profiling reveals miR-206 inhibits MET in lung cancer metastasis.
    Chen QY; Jiao DM; Yan L; Wu YQ; Hu HZ; Song J; Yan J; Wu LJ; Xu LQ; Shi JG
    Mol Biosyst; 2015 Aug; 11(8):2290-302. PubMed ID: 26075299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STAT3 is involved in miR-124-mediated suppressive effects on esophageal cancer cells.
    Cheng Y; Li Y; Nian Y; Liu D; Dai F; Zhang J
    BMC Cancer; 2015 Apr; 15():306. PubMed ID: 25928665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of MiR-210 on proliferation, apoptosis and invasion abilities of esophageal cancer cells.
    Cheng Z; Geng H; Cheng Y; Dong N; Ning F; Yu Z; Jian J; Chen S
    J BUON; 2018; 23(3):814-819. PubMed ID: 30003756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and effects of miR-21 expression in esophageal cancer.
    Wen SW; Zhang YF; Li Y; Liu ZX; Lv HL; Li ZH; Xu YZ; Zhu YG; Tian ZQ
    Genet Mol Res; 2015 Aug; 14(3):8810-8. PubMed ID: 26345812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-150-5p inhibits hepatoma cell migration and invasion by targeting MMP14.
    Li T; Xie J; Shen C; Cheng D; Shi Y; Wu Z; Zhan Q; Deng X; Chen H; Shen B; Peng C; Li H; Zhu Z
    PLoS One; 2014; 9(12):e115577. PubMed ID: 25549355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-125a-5p modulates human cervical carcinoma proliferation and migration by targeting ABL2.
    Qin X; Wan Y; Wang S; Xue M
    Drug Des Devel Ther; 2016; 10():71-9. PubMed ID: 26766902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-302b inhibits cancer-related inflammation by targeting ERBB4, IRF2 and CXCR4 in esophageal cancer.
    Zhang M; Zhang L; Cui M; Ye W; Zhang P; Zhou S; Wang J
    Oncotarget; 2017 Jul; 8(30):49053-49063. PubMed ID: 28467773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of cystatin C and its effect on EC9706 cells in esophageal carcinoma.
    Yan Y; Zhou K; Wang L; Zhou Y; Chen X; Fan Q
    Int J Clin Exp Pathol; 2015; 8(9):10102-11. PubMed ID: 26617717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of Aurora-A kinase promotes tumor cell proliferation and inhibits apoptosis in esophageal squamous cell carcinoma cell line.
    Wang XX; Liu R; Jin SQ; Fan FY; Zhan QM
    Cell Res; 2006 Apr; 16(4):356-66. PubMed ID: 16617331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.